中文

我武生物 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-24
ItemAmountY/Y
Revenue¥0.25B+10.7%
Gross profit¥0.24B
Operating income¥0.13B
Net income¥0.12B+62.8%
Gross margin95.2%Net margin 46.1%
Revenue Q/Q+21.0%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.01B4.8%
R&D¥0.02B9.9%
SG&A¥0.12B46.3%
Tax & other¥0.02B6.6%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

楚天科技全通教育炬华科技博腾股份中文在线恒华科技ST创意汇金股份绿盟科技安控科技汇中股份扬杰科技

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies